Promise of liquid biopsy in cancer biomarker detection and prenatal screening

(Mary Ann Liebert, Inc./Genetic Engineering News) The promise and challenges of liquid biopsy, an emerging, noninvasive method for targeted disease diagnosis and detection of cancer biomarkers to enable improved and personalized therapy, is the focus of a new special issue of Genetic Testing and Molecular Biomarkers, a peer-reviewed journal from Mary Ann Liebert Inc. publishers.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news